Efficacy and Safety of Nilotinib (AMN107) Compared With Current Treatment Options in Patients With GIST Who Have Failed Both Imatinib and Sunitinib
Clinical trial NCT00471328 · COMPLETED
Trial details
- NCT number
- NCT00471328
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2008-08-01
- Enrollment
- 248
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.